Bioventus Inc. (BVS) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $568.09M | -0.9% |
| 2024 | $573.28M | +11.9% |
| 2023 | $512.35M | +0.0% |
| 2022 | $512.12M | +18.8% |
| 2021 | $430.90M | +34.2% |
| 2020 | $321.16M | -5.6% |
| 2019 | $340.14M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $568.09M | -0.9% |
| 2024 | $573.28M | +11.9% |
| 2023 | $512.35M | +0.0% |
| 2022 | $512.12M | +18.8% |
| 2021 | $430.90M | +34.2% |
| 2020 | $321.16M | -5.6% |
| 2019 | $340.14M | — |